Summit Therapeutics Inc.

BMV:SMMT * Stock Report

Market Cap: Mex$278.8b

Summit Therapeutics Future Growth

Future criteria checks 0/6

Summit Therapeutics is forecast to grow revenue at 85.4% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth0%
Revenue growth rate85.4%
Future return on equity-29.4%
Analyst coverage

Low

Last updated18 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

BMV:SMMT * - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202648N/AN/A-2864
12/31/2025N/AN/AN/A-1654
12/31/2024N/AN/AN/A-1484
9/30/2024N/A-197-128-113N/A
6/30/2024N/A-162-98-97N/A
3/31/2024N/A-116-94-94N/A
12/31/2023N/A-615-552-77N/A
9/30/2023N/A-598-527-52N/A
6/30/20230-598-521-46N/A
3/31/20230-600-511-36N/A
12/31/20221-79-42-42N/A
9/30/20221-87-57-56N/A
6/30/20222-85-72-71N/A
3/31/20222-93-72-71N/A
12/31/20212-89-73-73N/A
9/30/20212-75-72-71N/A
6/30/20211-73-65-64N/A
3/31/20211-64-64-64N/A
12/31/20201-53-49-48N/A
9/30/20201-51-49-49N/A
6/30/20201-40-38-37N/A
3/31/2020-5-31-18-18N/A
12/31/20191-32-23-23N/A
10/31/201926-28-24-23N/A
7/31/201924-27-20-19N/A
4/30/20197212-24-24N/A
1/31/20195711-35-35N/A
10/31/2018702-36-36N/A
7/31/20187211N/A-45N/A
4/30/201827-29N/A-19N/A
1/31/201820-29N/A-21N/A
10/31/201715-18N/A-20N/A
7/31/201712-23N/A31N/A
4/30/20175-27N/A14N/A
1/31/20173-27N/A15N/A
10/31/20161-29N/A15N/A
7/31/20161-33N/A-26N/A
4/30/20161-32N/A-29N/A
1/31/20162-29N/A-24N/A
10/31/20152-25N/A-23N/A
7/31/20153-20N/A-20N/A
4/30/20153-19N/A-21N/A
1/31/20153-17N/A-17N/A
10/31/20143-17N/A-16N/A
7/31/20144-17N/A-16N/A
4/30/20144-13N/A-11N/A
1/31/20143-10N/A-10N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if SMMT *'s forecast earnings growth is above the savings rate (8.1%).

Earnings vs Market: Insufficient data to determine if SMMT *'s earnings are forecast to grow faster than the MX market

High Growth Earnings: Insufficient data to determine if SMMT *'s earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: SMMT * is forecast to have no revenue next year.

High Growth Revenue: SMMT * is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: SMMT * is forecast to be unprofitable in 3 years.


Discover growth companies